Product Program year 2022 Source: CMS Open Payments

V-Go Disposable Insulin Delivery

Device Diabetes

PDI 00385609600029

Open in the dashboard

General payments

$6,348

338 payments

Research payments

$0

0 payments

Through program year 2022, $6,348 in general payments and $0 in research payments were reported against V-Go Disposable Insulin Delivery (Diabetes).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $6,348 338

Breakdown

Who paid General payments · program year 2022
  1. Zealand Pharma US, Inc. $6,348 338 payments
Top recipients General payments · program year 2022
  1. Daniel Tung Endocrinology, Diabetes & Metabolism · Houston, TX $158 2% · 10 payments
  2. Umara Jamal Endocrinology, Diabetes & Metabolism · Houston, TX $118 2% · 8 payments
  3. Shreya Parikh Endocrinology, Diabetes & Metabolism · Sugar Land, TX $91 1% · 4 payments
  4. Anjani Pandya Endocrinology, Diabetes & Metabolism · Sugar Land, TX $91 1% · 4 payments
  5. Niyati Hariyani Physician Assistant · Houston, TX $91 1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $2,511 40% · 78 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $1,501 24% · 45 practitioners
  3. Physician Assistant $549 9% · 18 practitioners
  4. Nurse Practitioner $362 6% · 15 practitioners
  5. Family Medicine $289 5% · 14 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $3,512 55% · 85 recipients
  2. California $410 6% · 20 recipients
  3. Ohio $245 4% · 12 recipients
  4. Nebraska $243 4% · 13 recipients
  5. Tennessee $235 4% · 15 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

338 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record